Coherus BioSciences Inc (NAS:CHRS)
$ 1.78 0.02 (1.14%) Market Cap: 204.21 Mil Enterprise Value: 423.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q1 2019 Coherus BioSciences Inc Earnings Call Transcript

May 09, 2019 / 08:30PM GMT
Release Date Price: $16.1 (-0.12%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Coherus BioSciences 2019 First Quarter Earnings Conference Call. My name is Dimitris, and I'll be your conference operator for the call today. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the call over to David Arrington, Vice President of Investor Relations and Corporate Affairs. Please go ahead, sir.

David Arrington
Coherus BioSciences, Inc. - VP of IR & Corporate Affairs

Thank you, Dimitris, and good afternoon, everyone. After close of market today, we issued our first quarter financial results press release. This release can be found on the Coherus BioSciences' website. Joining me for today's call will be Coherus' President and CEO, Denny Lanfear; Chief Financial Officer, Jean Viret; Chief Legal Officer, Thomas Fitzpatrick; and Senior Vice President of Marketing and Market Access, Jim Hassard.

Before we begin our formal remarks, I would like to remind you that we would be making forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot